Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease

J Neurol. 2017 Feb;264(2):333-340. doi: 10.1007/s00415-016-8348-0. Epub 2016 Nov 29.

Abstract

Cardiac parasympathetic function is strongly affected by aging. Although sympathetic dysfunction has been well documented in Parkinson's disease (PD), cardiac parasympathetic dysfunction has not been well studied. The objective of this study was to clarify the development of cardiac parasympathetic dysfunction in the early phase of PD and to explore the age-corrected correlation between cardiac parasympathetic dysfunction and cardiac sympathetic dysfunction. We reviewed 25 healthy controls and 56 patients with idiopathic PD of Hoehn and Yahr stages I-III. We evaluated cardiac parasympathetic function using the Valsalva ratio, the baroreflex sensitivity (BRS) and the coefficient of variation of RR intervals in the resting state (resting-CVRR) and during deep breathing (DB-CVRR). In addition, we measured cardiac 123I-metaiodobenzylguanidine (MIBG) uptake to investigate the relationship between cardiac sympathetic and parasympathetic dysfunction in PD. Compared with healthy controls, patients with PD showed significantly decreased cardiac parasympathetic parameters (resting-CVRR 2.8 ± 1.3 vs. 1.7 ± 0.6%, p < 0.001; DB-CVRR 5.8 ± 2.3 vs. 3.8 ± 1.7%, p < 0.001; Valsalva ratio 1.52 ± 0.26 vs. 1.34 ± 0.17, p < 0.01; BRS 10.6 ± 9.5 vs. 5.0 ± 5.4 ms/mmHg, p < 0.01). In particular, resting-CVRR and DB-CVRR were significantly decreased in the early phase of PD. In age-corrected analyses, none of the parasympathetic indices correlated with the delayed cardiac 123I-MIBG uptake. These observations indicate that cardiac parasympathetic dysfunction occurs in the early phase of PD, but not necessarily in parallel with cardiac sympathetic dysfunction.

Keywords: Autonomic dysfunction; Autonomic nervous system; Cardiac 123I-metaiodobenzylguanidine scintigraphy; Cardiac parasympathetic dysfunction; Parkinson’s disease.

MeSH terms

  • 3-Iodobenzylguanidine
  • Aged
  • Aging / physiology
  • Autonomic Nervous System Diseases / drug therapy
  • Autonomic Nervous System Diseases / etiology
  • Autonomic Nervous System Diseases / physiopathology*
  • Blood Pressure
  • Blood Pressure Determination
  • Disease Progression
  • Female
  • Heart / diagnostic imaging
  • Heart / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Myocardial Perfusion Imaging
  • Parkinson Disease / complications
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology*
  • Radiopharmaceuticals
  • Severity of Illness Index
  • Tilt-Table Test
  • Valsalva Maneuver

Substances

  • Radiopharmaceuticals
  • 3-Iodobenzylguanidine